Biology

Dr. San Kim
Team Head of NGS Overseas Sales, Macrogen Inc., Korea

Abstract:

Macrogen is a precision medical and biotechnology company with a global reach. Established on June 5, 1997 from the Genome Medical Research Institute of Seoul National University, Macrogen became Korea’s first bio venture company listed on KOSDAQ in February 2000. Now, it has about 18,000 lab customers in 153 countries.

Macrogen has following NGS instruments installed at their facility.

- HiSeq X Ten – 20 Units

- NovaSeq 6000 – 3 Unit

- HiSeq 2500 / HiSeq 4000 – 17 Units

- NextSeq 500 / MiSeq – 9 Units

- PacBio RSII / PacBio Sequel – 2 Units

- Ion PGM – 2 Units

- Ion Proton – 10 Units

The presentation will focus on NGS capabilities of Macrogen and how they can help accelerate your research.